To save researchers time and resources, The Michael J. Fox Foundation has made a number of tools available to the scientific community at low cost, with rapid delivery.
Helpful Resources
-
Sponsored Tools Program
Learn more about how MJFF can help share your tools.
-
Tools Consortium
MJFF is working with industry to develop priority tools.
-
Preclinical Models
Learn more about the various in vivo models used in Parkinson's disease research.
Find a Research Tool
Filter by Tool Type or Gene/Protein Type to Organize Results
* = MJFF does not control pricing or terms of availability for this tool.
-
GAK Protein**
Human GAK Protein. This protein was generated and shared by Drs Paul Brennan and Karolina Rygiel at Oxford University though the MJFF Sponsored Tools Program.
-
FYN Protein*
Human FYN Protein. This protein was generated and shared by Drs Paul Brennan and Karolina Rygiel at Oxford University though the MJFF Sponsored Tools Program.
-
Cathepsin B Protein**
Human Cathepsin B Protein. This protein was generated and shared by Drs Paul Brennan and Karolina Rygiel at Oxford University though the MJFF Sponsored Tools Program.
-
BAG3 Protein*
Human BAG3 protein. This protein was generated and shared by Drs Paul Brennan and Karolina Rygiel at Oxford University though the MJFF Sponsored Tools Program.
-
pS65 Ubiquitin Immunoassay**
SMCxPRO® immunoassay for measurement of phospho-serine 65 Ubiquitin. Assay was developed and kindly shared by Mitokinin through the MJFF Sponsored Tools Program.
To access, complete the request form on the Millipore CADI services page.
-
Glucosylceramide Antibody
Rabbit monoclonal antibody directed against human/rodent glucosylceramide.
Estimated Availability: Late 2026
-
Mouse GCase Antibody
Rabbit monoclonal antibody directed against mouse GCase for immunostaining applications.
Estimated Availability: Late 2025
-
Human GCase Antibody
Rabbit monoclonal antibody directed against human GCase for immunostaining applications.
Estimated Availability: Late 2025
Email tools@michaeljfox.org with questions and to suggest new tools for us to develop. Or visit our FAQ page.